Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

4.10
Delayed Data
As of 4:00pm ET
 -0.16 / -3.76%
Today’s Change
2.72
Today|||52-Week Range
15.63
-7.87%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close4.26
Today’s open4.25
Day’s range4.07 - 4.30
Volume68,004
Average volume (3 months)196,758
Market cap$220.1M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-10.88%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.40

Competitors

 Today’s
change
Today’s
% change
CMRXChimerix Inc0.000.00%
FLKSFlex Pharma Inc+0.03+0.24%
PETXAratana Therapeutics...+0.62+9.98%
MNOVMediciNova Inc-0.02-0.30%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts

Partner Offers

Search for Jobs